Prospect News: News for Pure Bioscience, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with P > Issuers starting with P, PP only > All stories on Pure Bioscience, Inc. > Stories on Pure Bioscience, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Pure Bioscience, Inc.

11/25/2015	PP	Pure Bioscience settles $8 million stock sale with $2 million tranche
10/26/2015	PP	Pure Bioscience takes in $6 million through private placement of stock
8/27/2014	PP	Pure Bioscience completes $4 million private placement of equity units
4/29/2014	PP	Pure Bioscience takes in $225,000 through private placement of stock
11/18/2013	PP	Pure Bioscience wraps $590,827 of $2.35 million placement of stock
10/15/2013	PP	Pure Bioscience sells $1.76 million of stock through private placement
8/20/2013	PP	Pure Bioscience raises $1.1 million through private placement of stock
4/29/2013	PP	Pure Bioscience takes in $200,000 in $400,000 placement of its shares
4/23/2013	PP	Pure Bioscience takes in $200,000 through private placement of shares
2/1/2013	PP	Pure Bioscience reports plans to conduct public sale of common stock
9/17/2012	PP	Pure Bioscience raises $4.78 million in public offering of stock
9/12/2012	PP	Pure Bioscience prices $4.16 million public offering of stock at $1.10
9/4/2012	PP	Pure Bioscience to price public sale of shares with 45-day greenshoe

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.